Feasibility study of Glucagon-like peptide-1 analogues for the optimization of Outcomes in obese patients undergoing AbLation for Atrial Fibrillation (GOAL-AF) protocol.
Kyaw Z WinMatthew ArmstrongRichard P SteedsManish KallaPublished in: Pilot and feasibility studies (2024)
Metchley Park Medical Society and University of Birmingham Starter Fellowship, British Heart Foundation Accelerator Grant, Abbott Investigator-Initiated Study Grant.
Keyphrases
- atrial fibrillation
- patients undergoing
- catheter ablation
- heart failure
- left atrial
- oral anticoagulants
- healthcare
- randomized controlled trial
- metabolic syndrome
- adipose tissue
- left atrial appendage
- direct oral anticoagulants
- type diabetes
- weight loss
- molecular docking
- percutaneous coronary intervention
- bariatric surgery
- obese patients
- coronary artery disease